[go: up one dir, main page]

HK1116095B - 用於治疗特别是慢性阻塞性肺疾病(copd)和哮喘的呼吸疾病的化合物组合 - Google Patents

用於治疗特别是慢性阻塞性肺疾病(copd)和哮喘的呼吸疾病的化合物组合 Download PDF

Info

Publication number
HK1116095B
HK1116095B HK08111844.7A HK08111844A HK1116095B HK 1116095 B HK1116095 B HK 1116095B HK 08111844 A HK08111844 A HK 08111844A HK 1116095 B HK1116095 B HK 1116095B
Authority
HK
Hong Kong
Prior art keywords
active ingredient
oxy
amino
hydroxy
chlorobenzyl
Prior art date
Application number
HK08111844.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1116095A1 (zh
Inventor
Tomas Eriksson
Johan Hansson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority claimed from PCT/SE2006/000970 external-priority patent/WO2007024182A1/en
Publication of HK1116095A1 publication Critical patent/HK1116095A1/zh
Publication of HK1116095B publication Critical patent/HK1116095B/zh

Links

HK08111844.7A 2005-08-26 2006-08-24 用於治疗特别是慢性阻塞性肺疾病(copd)和哮喘的呼吸疾病的化合物组合 HK1116095B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0501896 2005-08-26
SE0501896 2005-08-26
SE0601220 2006-06-01
SE0601220 2006-06-01
PCT/SE2006/000970 WO2007024182A1 (en) 2005-08-26 2006-08-24 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma.

Publications (2)

Publication Number Publication Date
HK1116095A1 HK1116095A1 (zh) 2008-12-19
HK1116095B true HK1116095B (zh) 2010-09-10

Family

ID=

Similar Documents

Publication Publication Date Title
AU2009202925B2 (en) A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma
EP3335707B1 (en) Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
US20100329996A1 (en) Novel Combination of Therapeutic Agents
EP4403231A2 (en) Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
WO2009090010A1 (en) Compositions comprising an antimuscarinic and a long-acting beta-agonist
US20110124613A1 (en) Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
EP2717867A1 (en) Dry powder inhaler compositions comprising umeclidinium
WO2010097114A1 (en) Novel combination of therapeutic agents
US20090298875A1 (en) A Combination of Compounds, Which Can be Used in the Treatment of Respiratory Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
HK1116095B (zh) 用於治疗特别是慢性阻塞性肺疾病(copd)和哮喘的呼吸疾病的化合物组合
US20080207577A1 (en) Combination I
CN101296701A (zh) 用于治疗呼吸系统疾病,尤其是慢性阻塞性肺病(copd)和哮喘的化合物的组合
HK1249407B (zh) 毒蕈碱受体拮抗剂和β-2肾上腺素受体激动剂的组合
CN101296698A (zh) 用于治疗呼吸系统疾病，尤其是慢性阻塞性肺病（copd）和哮喘的化合物的组合
HK1174249A (zh) 毒蕈碱受体拮抗剂和β-2肾上腺素受体激动剂的组合